{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:33:35Z","timestamp":1774496015074,"version":"3.50.1"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[1979,8,1]],"date-time":"1979-08-01T00:00:00Z","timestamp":302313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1979,8]]},"abstract":"<jats:p>\n            <jats:italic>Candida lusitaniae<\/jats:italic>\n            associated with infection in a patient with acute myelogenous leukemia developed resistance to amphotericin B during systemic treatment of the patient. The organism, when isolated initially, was inhibited by 0.31 \u03bcg of amphotericin B per ml in yeast nitrogen base agar, but when isolated (20 days later) just antemortem and postmortem, required 100 and 50 \u03bcg\/ml, respectively, for complete inhibition at 48 h.\n          <\/jats:p>","DOI":"10.1128\/aac.16.2.123","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T23:57:02Z","timestamp":1340841422000},"page":"123-126","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":154,"title":["Development of Resistance to Amphotericin B in\n            <i>Candida lusitaniae<\/i>\n            Infecting a Human"],"prefix":"10.1128","volume":"16","author":[{"given":"D.","family":"Pappagianis","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, University of California, Davis, California 95616,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, University of California, Davis, California 95616,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hector","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, University of California, Davis, California 95616,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Remington","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Stanford School of Medicine, Stanford, California 94305"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.16.2.123","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.16.2.123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T13:50:23Z","timestamp":1645451423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.16.2.123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,8]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1979,8]]}},"alternative-id":["10.1128\/AAC.16.2.123"],"URL":"https:\/\/doi.org\/10.1128\/aac.16.2.123","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,8]]},"assertion":[{"value":"1979-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}